Home LiteratureArticle Details
PMID: 721951 Published · ppublish English Journal Article

Plasma concentrations of isosorbide dinitrate after cutaneous and sublingual doses to human subjects.

Journal of clinical pharmacology ·Vol. 18 ·No. 11-12 ·1978-00-00 ·Pages 544-8

Mansel-Jones D, Taylor T, Doyle E, Chasseaud LF, Darragh A, O'Kelly DA, Over H

Abstract

After application of 100 mg (nominal dose) isosorbide dinitrate as an ointment to the skin of human subjects, mean drug concentrations were 1 to 2 ng/ml for 1.5 hour and reached a peak of 6.2 ng/ml at 6 hours. Thereafter, mean concentrations declined slowly to 2.9 ng/ml at 12 hours and 1.2 ng/ml at 24 hours. After a sublingual dose of 5 mg isosorbide dinitrate, mean drug concentrations reached a peak of 15.9 ng/ml at 0.5 hour and declined with a half-life of about 50 minutes. The mean bioavailability of isosorbide dinitrate from the ointment was estimated as 30 per cent of that from the sublingual tablet when corrected for differences in dose/body weight ratio. The results demonstrate that concentrations of isosorbide dinitrate in plasma can be maintained for relatively long periods when the drug is applied to the skin.

MeSH Terms
Administration, Topical Adult Biological Availability Half-Life Humans Isosorbide Dinitrate/administration & dosage,blood Male Mouth Floor Time Factors
Chemicals
Isosorbide Dinitrate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Mansel-Jones D
Taylor T
Doyle E
Chasseaud L F
Darragh A
O'Kelly D A
Over H
Article Info
Journal
Journal of clinical pharmacology
Abbr.
J Clin Pharmacol
ISSN
0091-2700
Published
1978-00-00
Pages
544-8
Language
English
Region
England
NLM ID
0366372
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com